Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model01:14

Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model

The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A higher...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated metabolomics and machine learning identify predictive biomarkers via SHAP analysis for sintilimab-induced rash in lung cancer patients.

Frontiers in pharmacology·2026
Same author

Relationship between oral health literacy and oral frailty among older adults in nursing homes: a latent profile analysis.

Frontiers in public health·2026
Same author

An explainable predictive machine learning model of oxaliplatin induced peripheral neuropathy based on clinical data: a retrospective single center.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

ELYS promotes hepatocellular carcinoma stemness by activating a FOXO6-NUP205 transcriptional module downstream of PI3K/AKT to drive Hedgehog signaling.

Cell & bioscience·2026
Same author

Unmet care needs among older people in residential care: a scoping review.

BMC geriatrics·2026
Same author

Dynamic frailty trajectories, multidimensional resilience, and risk of incident hip fracture: A prospective cohort study with competing risk analysis.

Archives of gerontology and geriatrics·2026

Related Experiment Video

Updated: Jun 3, 2026

Quantitative [18F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain
06:31

Quantitative [18F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain

Published on: August 8, 2019

Two-level time-domain decomposition based distributed method for numerical solutions of pharmacokinetic models.

Li Liu1, Choi-Hong Lai, Shao-Dan Zhou

  • 1School of IoT Engineering, Jiangnan University, Wuxi 214122, Jiangsu Province, China. liuli_sytu@hotmail.com

Computers in Biology and Medicine
|March 15, 2011
PubMed
Summary

Predicting drug concentration variations requires efficient numerical solutions for pharmacokinetic models. A new Inverse Laplace method for Pharmacokinetic models (ILPK) and its distributed version offer accurate and efficient predictions for both linear and nonlinear models.

More Related Videos

A Method for Determination and Simulation of Permeability and Diffusion in a 3D Tissue Model in a Membrane Insert System for Multi-well Plates
10:33

A Method for Determination and Simulation of Permeability and Diffusion in a 3D Tissue Model in a Membrane Insert System for Multi-well Plates

Published on: February 23, 2018

Related Experiment Videos

Last Updated: Jun 3, 2026

Quantitative [18F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain
06:31

Quantitative [18F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain

Published on: August 8, 2019

A Method for Determination and Simulation of Permeability and Diffusion in a 3D Tissue Model in a Membrane Insert System for Multi-well Plates
10:33

A Method for Determination and Simulation of Permeability and Diffusion in a 3D Tissue Model in a Membrane Insert System for Multi-well Plates

Published on: February 23, 2018

Area of Science:

  • Pharmacokinetics
  • Computational modeling
  • Numerical analysis

Background:

  • Efficient prediction of drug concentration variations is crucial for pharmacokinetic modeling.
  • Traditional analytical solutions for linear models are limited, and numerical methods like RK4 struggle with complex nonlinear models and distributed computing.
  • Existing methods for nonlinear pharmacokinetic models are often computationally intensive and difficult to implement robustly.

Purpose of the Study:

  • To adapt time-domain decomposition methods for solving nonlinear pharmacokinetic models efficiently.
  • To introduce and evaluate the numerical Inverse Laplace method for Pharmacokinetic models (ILPK) for both linear and nonlinear models.
  • To develop and assess a distributed ILPK algorithm for enhanced computational efficiency.

Main Methods:

  • Implementation of the numerical Inverse Laplace method for Pharmacokinetic models (ILPK) using iterative inverse Laplace transforms.
  • Development of a distributed ILPK algorithm based on a two-level time-domain decomposition strategy.
  • Concurrent computation on finer temporal meshes leveraging solutions from a coarser temporal mesh.

Main Results:

  • The ILPK algorithm demonstrates accuracy and efficiency in solving pharmacokinetic models.
  • The distributed ILPK algorithm significantly improves computational efficiency through parallel processing.
  • Both ILPK and its distributed version are effective for both linear and nonlinear pharmacokinetic models.

Conclusions:

  • The ILPK algorithm provides an efficient and accurate approach for pharmacokinetic model predictions.
  • The distributed ILPK algorithm enhances computational performance, making it suitable for complex simulations.
  • These methods represent promising tools for advancing pharmacokinetic research and drug development.